Literature DB >> 16677361

Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia.

Rudolph P Valentini1, Abubakr Imam, Indira Warrier, Demetrius Ellis, A Kim Ritchey, Yaddanapudi Ravindranath, Ron Shapiro, Michael L Moritz.   

Abstract

Autoimmune hemolytic anemia (AIHA) has been reported to occur after renal transplantation, and typically does so in the first few weeks post-transplant. We report on a 3-yr-old child who developed cold AIHA nearly 1 yr after an ABO identical, living donor renal transplant from his mother. Numerous transfusions, pulse steroids, repeat plasma exchange treatments, and IVIG were unsuccessful. Nearly 3 wk into his illness, tacrolimus was changed to cyclosporine, and then to sirolimus, and resulted in a prompt response. He currently has a normal renal function and a normal hemoglobin level on sirolimus monotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677361     DOI: 10.1111/j.1399-3046.2005.00460.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  7 in total

Review 1.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  Growth failure associated with sirolimus: case report.

Authors:  Gloria A Rangel; Gema Ariceta
Journal:  Pediatr Nephrol       Date:  2009-06-03       Impact factor: 3.714

Review 3.  Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.

Authors:  J Michael Tredger; Nigel W Brown; Anil Dhawan
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Treatment and outcomes of immune cytopenias following solid organ transplant in children.

Authors:  Michelle Schoettler; Scott A Elisofon; Heung Bae Kim; Elizabeth D Blume; Nancy Rodig; Debra Boyer; Ellis J Neufeld; Rachael F Grace
Journal:  Pediatr Blood Cancer       Date:  2014-10-12       Impact factor: 3.167

5.  Autoimmune haemolytic anaemia associated with Epstein Barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report.

Authors:  Alexander J Hamilton; Lynsey H Webb; Jennifer K Williams; Richard J D'Souza; Loretta S P Ngu; Jason Moore
Journal:  BMC Nephrol       Date:  2015-07-18       Impact factor: 2.388

6.  Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives.

Authors:  Wilma Barcellini; Bruno Fattizzo; Anna Zaninoni
Journal:  J Blood Med       Date:  2019-08-08

Review 7.  Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Nataliya Prokopenko Buxbaum; Steven Z Pavletic
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.